Rapid Fire Abstract session: new insights in cardiomyopthies434The role of 4D echocardiography and cardiac biomarkers for early detection of chemotherapy induced cardiotoxicity in nonHodgkin lymphoma patients435Identification of proto-oncogenes and genes responsible for myocardial fibrosis and diastolic dysfunction after anticancer treatment under experimental conditions436Wild type transthyretin cardiac amyloidosis: clinical characteristics, echocardiographic findings, and predictors of outcome437A novel echocardiographic index for detection of cardiac amyloidosis.438Left ventricular outflow obstruction is a treatable feature rather than a risk marker in patients with hypertrophic cardiomyopathy439The international stress echo registry in hypertrophic cardiomyopathy440Value of left atrial size and function to risk stratify for new onset atrial fibrillation in hypertrophic cardiomyopathy441Right ventricle ejection fraction by cardiac resonance imaging is superior in discrimination between early phase ARVC and right ventricular outflow tract ventricular tachycardia

Autor: J Saberniak, P Debonnaire, Q Ciampi, L Faber, E Pagourelias, M Grogan, J Bergler-Klein, D Mihalcea, M Florescu, AM Vladareanu, S Mihaila, D Vinereanu, A Spannbauer, K Zlabinger, D Macejovska, G Maurer, M Gyongyosi, C Scott, G Lin, K Klarich, W Miller, A Dispenzieri, OC Mirea, J Duchenne, G Vovas, L Van Aelst, P Claus, J Van Cleemput, M Delforge, J Bogaert, JU Voigt, A Burghardt, H Seggewiss, F Van Buuren, D Horstkotte, I Olivotto, C Gardini, L Monserrat, J Peteiro, L Lopes, C Cotrim, MA Losi, DE Lazzeroni, E Picano, E Joyce, OVW Van Den Brink, JJ Bax, V Delgado, N Ajmone Marsan, IS Leren, TF Haland, E Hopp, T Edvardsen, KH Haugaa

Publikováno v: European Heart Journal – Cardiovascular Imaging. 16:S51-S53

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5a757e3fd6a50176b4778046f85c58e1
https://doi.org/10.1093/ehjci/jev254

Splanchnic vein thrombosis, the onset manifestation in JAK positive Chronic Myeloproliferative Disorders Neoplasms

Autor: Am, Vladareanu, Popov V, Bumbea H, Minodora Onisai, Ilea A, Dobrea C, Miulescu M

Publikováno v: Scopus-Elsevier
Journal of Medicine and Life
Europe PubMed Central

Background: Patients with Myeloproliferative Neoplasms–(MPN) have a high risk of thrombotic complications. Portal vein thrombosis is a severe complication, which in many cases, appears at the onset of the disease; the risk factors are related to th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::31ffbbece85120020a466b4c1cc14f40
http://www.scopus.com/inward/record.url?eid=2-s2.0-79957797733&partnerID=MN8TOARS

Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast-phase BCR::ABL1-negative myeloproliferative neoplasms.

Autor: Gurban P; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Cytogenomic Medical Laboratory, Bucharest, Romania., Mambet C; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Hematology Department, Emergency University Clinical Hospital, Bucharest, Romania., Botezatu A; Molecular Virology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Necula LG; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Matei L; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Neagu AI; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Infectious Diseases, Epidemiology, Microbiology, Parasitology, Virology, Diabetes, Endocrinology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Pitica I; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Ataman M; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Tatic A; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Bardas A; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Gaman MA; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Dobrea C; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Dragomir M; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Ghimici C; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Angelescu S; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Barbu D; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Stanca O; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Danila M; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Berbec N; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Colita A; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Vladareanu AM; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Hematology Department, Emergency University Clinical Hospital, Bucharest, Romania., Nedeianu S; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Chivu-Economescu M; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Bleotu C; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Coriu D; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Sepulchre E; de Duve Institute, Université catholique de Louvain, Brussels, Belgium., Anton G; Molecular Virology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Diaconu CC; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Constantinescu SN; de Duve Institute, Université catholique de Louvain, Brussels, Belgium.; SIGN (Cell Signalling and Molecular Hematology), Ludwig Institute for Cancer Research Brussels, Brussels, Belgium.; Walloon Excellence in Life Sciences and Biotechnology (WELBIO) Department, WEL Research Institute, Wavre, Belgium.; Nuffield Department of Medicine, Ludwig Institute for Cancer Research, Oxford University, Oxford, UK.

Publikováno v: American journal of hematology [Am J Hematol] 2024 Oct 19. Date of Electronic Publication: 2024 Oct 19.

Immune dysfunction in patients with end stage kidney disease; Immunosenescence - Review.

Autor: Bumbea VI; Clinical Emergency Hospital Bucharest, Dialysis Department, Romania., Bumbea H; University Emergency Hospital, Bucharest, Hematology Department, Romania.; Carol Davila, Bucharest, University of Medicine and Pharmacy Romania., Vladareanu AM; University Emergency Hospital, Bucharest, Hematology Department, Romania.; Carol Davila, Bucharest, University of Medicine and Pharmacy Romania.

Publikováno v: Romanian journal of internal medicine = Revue roumaine de medecine interne [Rom J Intern Med] 2024 Mar 23; Vol. 62 (1), pp. 12-19. Date of Electronic Publication: 2024 Mar 23 (Print Publication: 2024).

Myocardial work-A new tool for early detection of rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone chemotherapy induced-cardiotoxicity in hematological patients.

Autor: Mihalcea D; Faculty of Medicine, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.; Cardiology Department, University and Emergency Hospital, Bucharest, Romania., Memis H; Cardiology Department, University and Emergency Hospital, Bucharest, Romania., Balinisteanu A; Cardiology Department, University and Emergency Hospital, Bucharest, Romania., Vladareanu AM; Faculty of Medicine, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.; Cardiology Department, University and Emergency Hospital, Bucharest, Romania., Mihaila S; Faculty of Medicine, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.; Cardiology Department, University and Emergency Hospital, Bucharest, Romania., Vinereanu D; Faculty of Medicine, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.; Cardiology Department, University and Emergency Hospital, Bucharest, Romania.

Publikováno v: Journal of clinical ultrasound : JCU [J Clin Ultrasound] 2023 Mar; Vol. 51 (3), pp. 377-384. Date of Electronic Publication: 2022 Nov 04.